INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,697 | -77.9% | 71,201 | -74.7% | 0.00% | – |
| Q2 2023 | $125,452 | -91.7% | 280,968 | -84.7% | 0.00% | – |
| Q1 2023 | $1,509,779 | -44.3% | 1,841,195 | +6.0% | 0.00% | -100.0% |
| Q4 2022 | $2,708,926 | -31.0% | 1,736,491 | -23.7% | 0.00% | 0.0% |
| Q3 2022 | $3,924,000 | +52.4% | 2,274,865 | +52.8% | 0.00% | 0.0% |
| Q2 2022 | $2,575,000 | -23.2% | 1,488,867 | +59.5% | 0.00% | 0.0% |
| Q1 2022 | $3,351,000 | -61.1% | 933,280 | -45.9% | 0.00% | -50.0% |
| Q4 2021 | $8,610,000 | -31.5% | 1,725,324 | -1.8% | 0.00% | -33.3% |
| Q3 2021 | $12,577,000 | +4.2% | 1,756,598 | +35.0% | 0.00% | 0.0% |
| Q2 2021 | $12,065,000 | +409.9% | 1,301,509 | +410.5% | 0.00% | +200.0% |
| Q1 2021 | $2,366,000 | +43.7% | 254,941 | +37.0% | 0.00% | – |
| Q4 2020 | $1,646,000 | -81.1% | 186,064 | -75.3% | 0.00% | -100.0% |
| Q3 2020 | $8,723,000 | -39.3% | 752,002 | +41.1% | 0.00% | -25.0% |
| Q2 2020 | $14,365,000 | +301.1% | 532,998 | +10.8% | 0.00% | +300.0% |
| Q1 2020 | $3,581,000 | +493.9% | 481,220 | +163.3% | 0.00% | – |
| Q4 2019 | $603,000 | +188.5% | 182,771 | +78.8% | 0.00% | – |
| Q3 2019 | $209,000 | -35.5% | 102,197 | -7.4% | 0.00% | – |
| Q2 2019 | $324,000 | -26.7% | 110,325 | -7.0% | 0.00% | – |
| Q1 2019 | $442,000 | -47.3% | 118,589 | -43.5% | 0.00% | – |
| Q4 2018 | $839,000 | -5.9% | 209,796 | +30.8% | 0.00% | – |
| Q3 2018 | $892,000 | +51.7% | 160,415 | +7.0% | 0.00% | – |
| Q2 2018 | $588,000 | -9.5% | 149,973 | +8.6% | 0.00% | – |
| Q1 2018 | $650,000 | +76.6% | 138,080 | +55.1% | 0.00% | – |
| Q4 2017 | $368,000 | -48.2% | 89,047 | -20.7% | 0.00% | – |
| Q3 2017 | $711,000 | -56.0% | 112,268 | -45.5% | 0.00% | – |
| Q2 2017 | $1,616,000 | +209.6% | 206,145 | +161.3% | 0.00% | – |
| Q1 2017 | $522,000 | -32.7% | 78,885 | -29.5% | 0.00% | – |
| Q4 2016 | $776,000 | 0.0% | 111,851 | +34.3% | 0.00% | – |
| Q3 2016 | $776,000 | +75.6% | 83,296 | +74.0% | 0.00% | – |
| Q2 2016 | $442,000 | +37.7% | 47,885 | +30.0% | 0.00% | – |
| Q1 2016 | $321,000 | -89.2% | 36,830 | -91.7% | 0.00% | -100.0% |
| Q4 2015 | $2,966,000 | +5.9% | 441,409 | -8.9% | 0.00% | 0.0% |
| Q3 2015 | $2,800,000 | +129.1% | 484,473 | +223.6% | 0.00% | – |
| Q2 2015 | $1,222,000 | +4.4% | 149,728 | +4.5% | 0.00% | – |
| Q1 2015 | $1,170,000 | -55.3% | 143,327 | -49.7% | 0.00% | -100.0% |
| Q4 2014 | $2,615,000 | -44.0% | 284,875 | -39.9% | 0.00% | 0.0% |
| Q3 2014 | $4,667,000 | -11.0% | 473,806 | -2.3% | 0.00% | -50.0% |
| Q2 2014 | $5,242,000 | – | 484,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |